PMDA — authorised 3 July 2017
- Marketing authorisation holder: Biogen Japan Ltd
- Status: approved
PMDA authorised Spinraza on 3 July 2017
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 3 July 2017.
Biogen Japan Ltd holds the Japanese marketing authorisation.